Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12617000191392Phase 4Recruiting
Phase 4, open-label, single-arm trial of rocuronium, sponsored by Prof. Thomas Ledowski. Primary endpoints: Perineal post pressure on the perineum/pudendal nerve region and Hip joint width change after neuromuscular paralysis. Started May 2017; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12617000191392.